These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10081818)

  • 1. Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivatives.
    Barlocco D; Cignarella G; Vianello P; Villa S; Pinna GA; Fadda P; Fratta W
    Farmaco; 1998; 53(8-9):557-62. PubMed ID: 10081818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanes.
    Barlocco D; Fadda P; Fratta W
    Farmaco; 1993 Mar; 48(3):387-96. PubMed ID: 8391821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, modelling, and mu-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicycl.
    Pinna GA; Murineddu G; Curzu MM; Villa S; Vianello P; Borea PA; Gessi S; Toma L; Colombo D; Cignarella G
    Farmaco; 2000 Aug; 55(8):553-62. PubMed ID: 11132733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity.
    Cignarella G; Barlocco D; Vianello P; Villa S; Pinna GA; Fadda P; Fratta W; Toma L; Gessi S
    Farmaco; 1998; 53(10-11):667-74. PubMed ID: 10205853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors.
    Cignarella G; Barlocco D; Tranquillini ME; Volterra A; Brunello N; Racagni G
    Pharmacol Res Commun; 1988 May; 20(5):383-94. PubMed ID: 2843931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided structure-affinity relationships in a set of piperazine and 3,8-diazabicyclo[3.2.1]octane derivatives binding to the mu-opioid receptor.
    Barlocco D; Cignarella G; Greco G; Novellino E
    J Comput Aided Mol Des; 1993 Oct; 7(5):557-71. PubMed ID: 8294946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications.
    Pinna GA; Cignarella G; Loriga G; Murineddu G; Mussinu JM; Ruiu S; Fadda P; Fratta W
    Bioorg Med Chem; 2002 Jun; 10(6):1929-37. PubMed ID: 11937351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazabicyclo[3.3.1]nonanone-type ligands for the opioid receptors.
    Kuhl U; Englberger W; Haurand M; Holzgrabe U
    Arch Pharm (Weinheim); 2000 Jul; 333(7):226-30. PubMed ID: 10965597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bicyclic piperazine homologues XIV (1). Synthesis and analgesic activity of 3,8-diaza-bicyclo[3.2.1.] octane derivatives].
    Ocelli E; Fontanella L; Diena A
    Farmaco Sci; 1978 Jun; 33(6):401-20. PubMed ID: 738456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive action of DBO 17 and DBO 11 in mice: two 3,8 diazabicyclo (3.2.1.) octane derivates with selective mu opioid receptor affinity.
    Fadda P; Barlocco D; Tronci S; Cignarella G; Fratta W
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):596-602. PubMed ID: 9402039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and opioid receptor affinity of a series of 2, 4-diaryl-substituted 3,7-diazabicylononanones.
    Siener T; Cambareri A; Kuhl U; Englberger W; Haurand M; Kögel B; Holzgrabe U
    J Med Chem; 2000 Oct; 43(20):3746-51. PubMed ID: 11020289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of bridgehead hydroxy bicyclo[2.2.2]octane derivatives.
    Thornqvist V; Manner S; Wingstrand M; Frejd T
    J Org Chem; 2005 Oct; 70(21):8609-12. PubMed ID: 16209621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors.
    Loriga G; Manca I; Murineddu G; Chelucci G; Villa S; Gessi S; Toma L; Cignarella G; Pinna GA
    Bioorg Med Chem; 2006 Feb; 14(3):676-91. PubMed ID: 16243530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bicyclic analogs of piperazine. XIII (1). Derivatives of 3,8-diazabicyclo[3.2.1]octane with potential anti-inflammatory activity].
    Fontanella L; Occelli E; Testa E
    Farmaco Sci; 1975 Sep; 30(9):742-53. PubMed ID: 1157922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diazabicycloalkane delta opioid agonists.
    Loriga G; Lazzari P; Manca I; Ruiu S; Falzoi M; Murineddu G; Bottazzi ME; Pinna G; Pinna GA
    Bioorg Med Chem; 2015 Sep; 23(17):5527-38. PubMed ID: 26252963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists.
    Huck BR; Llamas L; Robarge MJ; Dent TC; Song J; Hodnick WF; Crumrine C; Stricker-Krongrad A; Harrington J; Brunden KR; Bennani YL
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2891-4. PubMed ID: 16546379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new n-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1-acetyldibenzo-[e.h]-bicyclo[2.2.2]-octane-2,3-dicarboximide.
    Kossakowski J; Szczepek W; Pakosińska-Parys M
    Acta Pol Pharm; 2002; 59(6):418-23. PubMed ID: 12669762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro muscarinic activities of a series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octanes.
    Plate R; Plaum MJ; van der Hulst RG; de Boer T
    Bioorg Med Chem; 2000 Feb; 8(2):449-54. PubMed ID: 10722168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.